Review
Published on 29 Sep 2022
In ovo model in cancer research and tumor immunology
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1006064
- 7,321 views
- 13 citations
Type at least 3 characters
5,354 articles
Articles
Original Research
Published on 29 Sep 2022
External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1011040
- 2,815 views
- 6 citations
Original Research
Published on 29 Sep 2022
Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.985051
- 3,245 views
- 4 citations
Original Research
Published on 28 Sep 2022
Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.985187
- 6,843 views
- 5 citations
Original Research
Published on 28 Sep 2022
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.990790
- 7,854 views
- 15 citations
Original Research
Published on 28 Sep 2022
Transcriptional states of CAR-T infusion relate to neurotoxicity – lessons from high-resolution single-cell SOM expression portraying
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.994885
- 2,635 views
- 2 citations
Original Research
Published on 28 Sep 2022
Prognostic value of programmed cell death ligand-1 expression in patients with bladder urothelial carcinoma undergoing radical cystectomy: A meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.986911
- 1,781 views
Review
Published on 28 Sep 2022
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1019115
- 7,825 views
- 9 citations
Review
Published on 28 Sep 2022
miR-aculous new avenues for cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.929677
- 3,027 views
Original Research
Published on 28 Sep 2022
Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.931429
- 3,239 views
- 1 citation
Editorial
Published on 27 Sep 2022
Editorial: The impact of the DNA damage response on anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1026194
- 1,056 views
- 1 citation
Original Research
Published on 27 Sep 2022
Efficacy of immune checkpoint inhibitor therapy in EGFR mutation-positive patients with NSCLC and brain metastases who have failed EGFR-TKI therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.955944
- 2,232 views
- 3 citations
Original Research
Published on 27 Sep 2022
Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.989275
- 2,570 views
- 3 citations
Review
Published on 27 Sep 2022
Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1005457
- 4,063 views
- 5 citations
Review
Published on 27 Sep 2022
Mechanism underlying circRNA dysregulation in the TME of digestive system cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.951561
- 3,320 views
- 4 citations
Systematic Review
Published on 27 Sep 2022
Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.971278
- 4,817 views
- 13 citations